SLXN logo

SLXN Silexion Therapeutics Ltd.

NASDAQ Global Market · Biotechnology · Healthcare

$2.66
-0.57 (-17.65%)

Silexion Therapeutics LTD is a biopharmaceutical company specializing in the discovery and advancement of RNA interference (RNAi)-based cancer therapies and their associated delivery systems, with a focus on treating aggressive solid tumors. The company's strategy for addressing these tumors relies on its proprietary LODER delivery platform. Its product pipeline features several key candidates: Si…

Market Cap: $70.3Ksilexion.com

Price

No data yet.

Social Signal Score

40
5d
—
30d
50
1 mentions
—
60d
40
2 mentions
—
90d
30
3 mentions
—
news: 3

Analyst Ratings

1 analyst
Buyconsensus
Strong Buy 0Buy 1Hold 0Sell 0Strong Sell 0

Revenue

$0.00
$0.00
Dec 2020Sep 2026

Analyst Estimates

FY2025
$-60.35
$-60.35–$-60.35
1 analysts
FY2026
$-47.00
$-47.00–$-47.00
1 analysts
FY2027
$-18.40
$-18.40–$-18.40
1 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Ilan Hadar
Sector
Healthcare
Industry
Biotechnology
Employees
14
Beta
-0.25
Country
IL
Piotroski score
1 / 9 (Weak)
Altman Z-score
-17.91
silexion.com